|
BASEL, Switzerland (AP) - Novartis AG has received European Union approval for flu vaccine Optaflu, the Swiss drugmaker said Wednesday.
Iceland and Norway also have approved Optaflu for use in vaccination against seasonal influenza, Novartis said, adding that its use of proprietary cell culture technology could help in the event of a flu pandemic.
"Optaflu marks the first major innovation in influenza vaccine manufacturing in over 50 years," said Dr. Joerg Reinhardt, chief executive of Novartis vaccines and diagnostics.
|